Historical Lifetimes of Drugs in England: Application to Value of Information and Cost-Effectiveness Analyses

Author： Hoyle Martin  

Publisher： Blackwell Publishing

ISSN： 1098-3015

Source： Value in Health, Vol.13, Iss.8, 2010-12, pp. : 885-892

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statin Therapy in Rheumatoid Arthritis: A Cost-Effectiveness and Value-of-Information Analysis

By Bansback Nick   Ara Roberta   Ward Sue   Anis Aslam   Choi Hyon K.  

PharmacoEconomics, Vol. 27, Iss. 1, 2009-01 ,pp. : 25-37

Adis International

Access to resources Recommend Favorite

Future Drug Prices and Cost-Effectiveness Analyses

By Hoyle Martin  

PharmacoEconomics, Vol. 26, Iss. 7, 2008-01 ,pp. : 589-602

Adis International

Access to resources Recommend Favorite

A systematic review of cost-effectiveness analyses of pharmacogenomic interventions

By Phillips Kathryn A   Van Bebber Stephanie L  

Pharmacogenomics, Vol. 5, Iss. 8, 2004-12 ,pp. : 1139-1149

Future Medicine

Access to resources Recommend Favorite

The Importance of Cost Inputs and Sensitivity Analyses in a Cost-Effectiveness Analysis

By PharmD Jenna L. Yoder  

Clinical Drug Investigation, Vol. 28, Iss. 7, 2008-01 ,pp. : 461-462

Adis International

Access to resources Recommend Favorite

The cost offsets and cost-effectiveness associated with pegylated drugs: a review of the literature

By Becker Russell   Dembek Carole   White Leigh Ann   Garrison Louis P  

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 12, Iss. 6, 2012-12 ,pp. : 775-793

Informa Healthcare

Access to resources Recommend Favorite